Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Iran J Pharm Res
Hlavní autoři: Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza
Médium: Artigo
Jazyk:Inglês
Vydáno: Shaheed Beheshti University of Medical Sciences 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://ncbi.nlm.nih.gov/pubmed/27980592
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky